Florida Department of HealthEPI UPDATE

A weekly publication by the Bureau of Epidemiology

For January 5, 2001

"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."

--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.

Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist

Don Ward, Surveillance Section Administrator, Epi Update Managing Editor

Jason Glisson, Epi Editorial Assistant

Bureau of Epidemiology Frequent Contributors:

Steven Wiersma, MD, MPH,

Deputy State Epidemiologist

Jodi Baldy, MPH,

Biological Scientist IV

Ursula E. Bauer, PhD,

Chronic Disease Epidemiologist

Lisa Conti, DVM, MPH,

State Public Health Veterinarian

Regional Epidemiologists:

Dolly Katz, PhD, MPH,

SE Florida

Roger Sanderson, RN, MA,

SW Florida

Carina Blackmore, MS Vet. Med., PhD,

NE Florida Carina Blackmore, MS Vet. Med., PhD,

Zuber Mulla, MSPH,

Central Florida Carina Blackmore, MS Vet. Med., PhD,

Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.

The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.

In this issue:

1. Announcing a Genetic Disorder Teleconference

2. Merlin Helpful Hints

3. Influenza and Respiratory Syncytial Virus Surveillance Summary Update

4. Weekly Disease Table


 

1. Identifying, Counseling and Testing Patients at Risk for Genetic Disorders Teleconference

Jane Correia, Environmental Specialist III, Bureau of Environmental Epidemiology

On January 18th from 10:00 a.m. – 12:00 p.m. EST you are invited to view an exciting teleconference entitled "Identifying, Counseling and Testing Patients at Risk for Genetic Disorders". The teleconference is presented as part of the Genetics & Your Practice series. Conference Room # 225-Q at 4042 Bald Cypress Way has been reserved for the teleconference. Participants can also view the program from any available conference room at headquarters. A Webcast link is also available. Go to www.wfsu.org. Click on the internet button. Click on Genetics & Your Practice teleconference. (This will only be available the day of the teleconference.)

The presentation is intended to familiarize participants with genetic screening and diagnostic tests by describing examples of preconception, prenatal, pediatric and adult onset genetic testing. The role of the health care provider and genetic counseling in these contexts will also be explored.

Course Objectives:

Identify the principles of genetics, genetic factors associated with health and disease, and new advances in genetic-health related technology.

Plan options for incorporating genetic health care services and information into your practice. Identify genetic health care services for patients.

Target audience: Physicians, nurses and other healthcare providers who are interested in learning more about genetics.

Continuing Education Credits: 2.0 Category 1 Continuing Medical Education Credits and 2.0 Nursing Continuing Education Credits will be offered. Participants must complete and return the evaluation form in order to received continuing education credits. Evaluation forms and instructions will be available online at http://www.folicacidnow.net/gyp/main.htm. Completed evaluation forms must be returned to Kimberlea Hauser-- Email: Khauser@hsc.usf.edu; Mailed: Ms. Kimberlea Hauser, M.B.A., USF Birth Defects Center, 17 Davis Boulevard, Suite 400; Tampa, FL 33606; Fax (813) 259-8849.

Program Materials: Download the Genetics and Your Practice materials from the website: http://mchneighborhood.ichp.edu/wagenetics/906317226.html A copy of the Genetics and Your Practice curriculum and Genetics & Your Practice Florida Resource Directory can also be obtained by contacting Jane Correia at 245-4444 ext. 2198.

Sponsors: The Florida Chapters of the March of Dimes, The Florida Department of Health, and Florida Birth Defects Registry. The speakers presenting this information are Dan Riconda, MS, CGC, Genetic Counselor, Arnold Palmer Hospital in Orlando and Shane Palmer, MS, CGC, Territory Manager, Genzyme Genetics in Miami.

Contact Person: If you have questions or need additional information, please contact Jane Correia at (850) 245-4444 ext. 2198.

 

 

2. Merlin Helpful Hints

Kathryn Snavely, MPH, Surveillance Section

The year 2001 is off to a great start with the Merlin Reporting System and Hepatitis Registry. A couple of months have passed since the first of the Merlin training sessions, so we have included some helpful hints using Merlin below:

Make sure you are logging onto the correct web site for Merlin production (the site with actual data). If your user ID is invalid you are probably trying to log onto the training web site. The correct site address for production is http://167.78.31.26/merlin. If you are still having trouble logging onto the system, email the Merlin Helpdesk.

When searching for a patient profile in the database, do your search on the first 3-4 letters of the last name. This will insure that your patient will be returned in the search results even if the last name may be misspelled.

Before entering data into the "resources" area for a hospital or medical center, decide how many physicians you want to include from the provider. Remember, only physicians and laboratories that report communicable disease diagnoses need to be part of Merlin. It is not necessary to enter every physician into the system.

Make your county Task List the first destination after logging into the Merlin Reporting System. The Task List will show you what cases have been entered into Merlin but not reported to the Bureau of Epidemiology. Additionally, the laboratory results Task List will display the potential stand-alone laboratory results entered at the Bureau of Epidemiology that require follow-up.

When reporting cases from your Task List use the Refresh button on the Internet Explorer tool bar to update the list and remove cases from the Task List..

For navigating around Merlin you can use the Back button on the Internet Explorer tool bar at the top of your screen. The small, black down arrow to the right of the Back button will give you a drop down menu of all the previous pages. The down arrow can be used to navigate two or three pages back from your current location, instead of hitting the Back button multiple times.

If you have any other questions, please contact Kathryn Snavely, S/C 205-4444, x2447 or email the Merlin Helpdesk

 

 

3. INFLUENZA AND RESPIRATORY SYNCYTIAL VIRUS SURVEILLANCE SUMMARY UPDATE

Carina Blackmore, MS Vet. Med., PhD, NE Florida

(Week ending December 23, 2000-Week 51)

Florida: Data from Florida still suggests low levels of influenza activity. Overall, two percent of 10911 patients seeking care by reporting physicians in the influenza sentinel surveillance network met the case definition for ILI during week 51. Influenza-like illness activity was detected in 14 of the 20 counties represented in this week’s data set. Higher flu activity than expected for this time of year (>3%) was reported by physicians in Duval, Escambia and Palm Beach counties. More than 10% of patients seen by sentinel physicians in Leon county were diagnosed with ILI. Influenza A (H1N1) was isolated from patients in Broward and Polk counties. Since October 1, 42 influenza isolations

have been reported to the state health office: 21 influenza A (H1N1) isolates from Broward, Charlotte, Duval, Escambia, Lake, Leon, Orange and Polk counties, one influenza A (H3N2) from Duval county, 9 untyped influenza A isolates from Alachua, Columbia, Hillsborough, Orange, Palm Beach and Pinellas counties) and 12 influenza B isolates from Brevard, Broward, Hillsborough, Leon and Volusia counties.

Respiratory syncytial virus (RSV) activity remains high in northeastern, central and the southwestern part of the state where 38.6-52.4% of tested specimens were positive for RSV. Nineteen percent of RSV specimens tested in the southeast were positive. Twelve hospital laboratories in the state participate in this program.

National report: During week 51 (December 17-23, 2000), 65 of the 830 specimens tested by the WHO and National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories were positive for influenza type A virus and 16 were positive for type B virus. Twelve (18%) of the influenza A isolates were typed. All of them were influenza A (H1N1). Since October 460 (3%) influenza isolates (174 influenza A (H1N1), 8 influenza A (H3N2) and 90 influenza B of 15,364 specimens tested in US laboratories have yielded virus. Three hundred and eighty-one (83%) of the 460 U.S. isolates have been reported from the West South Central [248 (65%)], Pacific [79 (21%)], and South Atlantic regions. Influenza A(H1N1) viruses have predominated in the West South Central and South Atlantic regions. In the West South Central region, the majority [223 (90%)] of isolates reported were from Texas. In the Pacific region, influenza type B viruses accounted for 65 (82%) of the 79 isolates reported. Fifty-three (67%) of the 79 influenza B viruses reported in the Pacific region were from Alaska.

CDC has antigenically characterized 33 U.S. virus isolates (6 influenza A (H3N2); 19 influenza A (H1N1) and 8 influenza B). They are all similar to respective vaccine strains.

The percentage of all deaths due to Pneumonia and Influenza (P&I) as reported by the vital statistics offices of 122 U.S. cities was 7.2% during week 51. This percentage is below the epidemic threshold of 8.3% for this time of year.

Influenza activity was assessed as regional by the state and territorial health departments in Colorado, Kentucky, New York, Oregon, Tennessee, Texas and Virginia). Thirty-four states reported sporadic influenza activity and no activity was reported from 7 states (Connecticut, Maine, Maryland, New Jersey, North Dakota Pennsylvania and Vermont).

During week 51, 2% of patient visits to U.S. sentinel physicians were due to influenza-like illness (ILI). The percentage of ILI was within baseline levels of 0% to 3% in 8 of 9 surveillance regions. Five percent of patient visits to sentinel physicians in the pacific region, including Hawaii and Alaska, were due to ILI.

 

 

4. Weekly Disease Table (Week 52) *

DISEASE

1997
TO DATE

1998
TO DATE

1999
TO DATE

3-YEAR
AVERAGE
TO DATE

1999
TOTAL
CASES

2000
TO DATE

Anthrax

0

0

0

0

0

0

Botulism

0

0

4

1.3

4

0

Brucellosis

0

3

3

2

3

2

Campylobacteriosis

1001

856

896

917.7

988

951

Ciguatera

10

7

2

6.3

2

14

Cryptosporidiosis

161

163

153

159

180

160

Cyclosporiasis

70

6

4

26.7

5

8

Dengue

7

5

3

5

3

5

Diphtheria

0

0

0

0

0

0

E. coli O157:H7

49

52

54

51.7

55

90

E. coli; other (known serotype)

6

11

13

10

15

15

Ehrlichiosis; Human

2

0

2

1.3

2

3

Encephalitis; Eastern Equine

3

0

2

1.7

3

0

Encephalitis; St. Louis

9

2

3

4.7

4

0

Encephalitis; post-infectious*

16

7

5

9.3

5

5

Encephalitis; other (known organism)

15

17

11

14.3

14

7

Giardiasis (acute)

1673

1470

1184

1442.3

1322

1308

Haemophilus influenzae*; invasive

28

39

43

36.7

51

68

Hansen's Disease (Leprosy)

3

4

3

3.3

3

4

Hantavirus Infection

0

0

0

0

0

0

Hemolytic Uremic Syndrome

5

11

7

7.7

7

13

Hemorrhagic Fever

0

0

0

0

0

0

Hepatitis A

589

492

721

600.7

796

541

Hepatitis B

383

407

444

411.3

528

472

Hepatitis C

NR

NR

48

NR

55

26

Hepatitis Non-A; Non-B

108

82

10

66.7

10

5

Hepatitis; perinatal B

NR

NR

2

NR

1

Hepatitis; unspecified

7

23

17

2

17

7

Hepatitis; +HBsAg; pregnant woman

NR

NR

163

NR

251

430

Lead Poisoning

1420

1676

1657

1584.3

1810

827

Legionellosis

27

37

22

28.7

27

46

Leptospirosis

0

2

1

1

1

1

Listeriosis

NR

NR

34

NR

37

30

Lyme Disease

35

59

40

44.7

51

51

Malaria

88

83

81

84

97

75

Measles

7

2

2

3.7

2

2

Meningococcal Disease (N. meningitidis)

146

129

117

130.7

122

115

Meningitis; Group B Streptococci

16

19

14

16.3

14

19

Meningitis; Haemophilus influenzae

12

11

13

12

13

12

Meningitis; Streptococcus pneumoniae

83

84

90

85.7

97

106

Meningitis; Listeria monocytogenes

4

7

9

6.7

14

7

Meningitis; other bacterial (inc. unspec.)

65

61

54

60

62

95

Mercury Poisoning

2

1

7

3.3

7

10

Mumps

13

11

5

9.7

6

5

Neurotoxic Shellfish Poisoning

0

0

0

0

0

0

Pertussis

57

38

77

57.3

85

46

Plague

0

0

0

0

0

0

Poliomyelitis

0

0

0

0

0

0

Psittacosis

0

2

0

0.7

0

2

Q Fever

NR

NR

NR

NR

NR

0

Rabies; Animal

273

214

173

220

186

161

Rocky Mountain Spotted Fever

4

2

2

2.7

2

2

Rubella; including congenital

3

4

1

2.7

1

3

Salmonellosis

2354

2755

2859

2656

3071

2577

Shigellosis

1522

2149

1388

1686.3

1491

1227

Smallpox

NR

NR

0

NR

0

0

Staph Aureus (GISA/VISA)

NR

NR

0

NR

0

0

Staph Aureus (GRSA/VRSA)

NR

NR

0

NR

0

0

Streptococcal Disease; invasive Group A

36

42

80

52.7

93

134

Streptococcus pneumoniae; invasive disease

210

423

571

401.3

701

1059

Tetanus

1

3

3

2.3

3

1

Toxoplasmosis

6

13

14

11

17

11

Typhoid Fever

14

14

23

17

23

12

Vibrio cholerae (serogrp O1)

0

0

0

0

0

0

Vibrio cholerae (serogrp Non-O1)

10

10

9

9.7

10

4

Vibrio vulnificus

18

32

23

24.3

23

13

Vibrio other (including unspecified)

31

69

44

48

48

35

Yellow Fever

0

0

0

0

0

0

* Last week’s disease table (52) should have been (51), officially making this current week (52). Sorry for any inconvenience.